These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32089454)

  • 1. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
    Kim KN; Qureshi MM; Huang D; Ko NY; Cassidy M; Oshry L; Hirsch AE
    Clin Breast Cancer; 2020 Apr; 20(2):e200-e213. PubMed ID: 32089454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
    Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
    Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk NZ; Utkan Z; Evrensel T; Sezgin E;
    J Am Coll Surg; 2021 Dec; 233(6):742-751.e5. PubMed ID: 34530124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
    Gultekin M; Yazici O; Eren G; Yuce D; Aksoy S; Ozisik Y; Guler N; Yazici G; Hurmuz P; Yildiz F; Altundag K; Gurkaynak M
    Breast; 2014 Dec; 23(6):775-83. PubMed ID: 25201554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
    Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.
    Reinhorn D; Mutai R; Yerushalmi R; Moore A; Amir E; Goldvaser H
    Breast; 2021 Aug; 58():173-181. PubMed ID: 34158167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
    Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Mazouni C; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; de La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Robain M; Filleron T; Cailliot C; Dalenc F
    Ann Surg Oncol; 2019 Feb; 26(2):356-365. PubMed ID: 30539492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
    Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
    J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
    Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
    Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Radiotherapy and Histological Risk Factors on Outcomes in Malignant Phyllodes Tumors.
    Wong RX; Koh YS; Wong FY; Kusumawidjaja G; Ng WL; Yeo RMC; Farid M; Sheng Chan JY; Yan Z; Gudi MA; Tan PH
    Clin Breast Cancer; 2020 Dec; 20(6):e695-e700. PubMed ID: 32636151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.
    Buszek SM; Lin HY; Bedrosian I; Tamirisa N; Babiera GV; Shen Y; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):795-802. PubMed ID: 31377160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy.
    Cao L; Cai G; Xu F; Yang ZZ; Yu XL; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
    Medicine (Baltimore); 2016 Aug; 95(32):e4230. PubMed ID: 27512838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.
    Mehdi M; Kong AL; Frebault J; Huang S; Huang CC; Cortina CS
    J Surg Res; 2021 Aug; 264():138-148. PubMed ID: 33823490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
    Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk Z; Utkan Z; Ozaslan C; Evrensel T; Uras C; Aksaz E; Soyder A; Ugurlu U; Col C; Cabioglu N; Bozkurt B; Uzunkoy A; Koksal N; Gulluoglu BM; Unal B; Atalay C; Yıldırım E; Erdem E; Salimoglu S; Sezer A; Koyuncu A; Gurleyik G; Alagol H; Ulufi N; Berberoglu U; Dulger M; Cengiz O; Sezgin E; Johnson R
    Ann Surg Oncol; 2018 Oct; 25(11):3141-3149. PubMed ID: 29777404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
    Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
    Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast.
    Kennedy WR; Gabani P; Acharya S; Thomas MA; Zoberi I
    Cancer Med; 2019 Apr; 8(4):1379-1388. PubMed ID: 30864198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.